Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Certificate of Incorporation
- 3.2 Bylaws
- 10.1 Subscription Agreement
- 10.2 License Agreement
- 10.3 Assignment and Assumption Agreement
- 10.4 Exclusive License Agreement
- 10.5 First Amendment to Exclusive License Agreement
- 10.6 Joint Development Agreement
- 10.7 Material Transfer Agreement and Licence
- 10.8 Employment Agreement
- 10.9 Employment Agreement
- 10.10 Mark Lowdell
- 10.11 Stock Incentive Plan
- 10.12 Incentive Option Agreement with Employees
- 10.13 Incentive Option Agreement with Non-employee Directors
- 10.14 Consulting Agreement
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.20 EX-10.20
- 21.1 Subsidiaries
- 23.2 Consent of Auditor
INMB similar filings
Filing view
External links
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this Registration Statement on Form S-1 (Amendment No. 2) of our report dated May 25, 2018 relating to INmune Bio, Inc.’s consolidated financial statements as of December 31, 2017 and 2016 and for the years ended December 31, 2017 and 2016. We also consent to the reference to our firm under the heading "Experts" appearing therein.
/s/ GBH CPAs, PC
GBH CPAs, PC
www.gbhcpas.com
Houston, Texas
August 30, 2018